Health Dictionary Find a Doctor

Renal papillary necrosis

For patient information page,click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

Synonyms and keywords:: Papillary necrosis, RPN

Overview


Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

Overview

Renal papillary necrosis is a form of nephropathy involving the ischemic necrosis of the renal papilla, which is supplied by the vasa recta. Renal papillary necrosis is a significant kidney disorder, which is associated with chronic conditions such as diabetes, sickle cell disease, urinary tract obstruction, urinary tract infection and long term use of analgesics containing phenacetin.

Historical Perspective

Renal papillary necrosis was first introduced by Friedrich in 1877, following urinary obstruction. Then, other associated factors such as diabetes, sickle cell disease and analgesics have been found.

Pathophysiology

It is thought that Renal papillary necrosis is the result of damage to interstitial medullary and papillary cells due to direct effect of diseases such as diabetes, sickle cell disease, urinary tract obstruction, renal vein thrombosis, upper urinary tract infection, tuberculosis, vasculitis, renal transplant rejection and long term analgesics use such as acetaminophen and NSAIDs. Decreased prostaglandin synthesis and subsequent reduced renal blood flow is an important mechanism for developing renal papillary necrosis. Accumulation of sickle-shaped RBCs in patients with sickle cell disease can lead to intravascular obstruction, blood stasis and thrombosis that results in ischemic necrosis of renal papillary and medullary cells.

Causes

Renal papillary necrosis is associated with damaging the renal medullary and papillary cells due to many diseases such as diabetes, sickle cell disease, urinary tract obstruction, renal vein thrombosis, pyelonephritis, tuberculosis, vasculitis, cirrhosis, renal transplant rejection and long term analgesics and alcohol abuse. In infants, it is associated with asphyxia, dehydration, and sepsis.

Classification

Renal papillary necrosis may be classified according to the severity of renal parenchymal lesions into two subtypes: Medullary and Papillary.

Differential Diagnosis

Renal papillary necrosis should be differentiated from other conditions presenting with acute flank or upper abdominal pain, hematuria, nausea and vomiting. The differentials include: nephrolithiasis, pyelonephritis, renal infarct, renal cell carcinoma, pelvic inflammatory disease, ovarian torsion, testicular torsion, prostatitis, prostatic cancer, ectopic pregnancy, orchitis, appendicitis, cholecystitis, ischemic colitis, peptic ulcer disease, portal vein thrombosis, diverticulitis, abdominal aortic aneurysm.

Epidemiology and Demographics

The prevalence and demographic characteristics of renal papillary necrosis depend on the causative agent.*Renal papillary necrosis due to analgesic abuse is more prevalent in Australia and England and less in the US. The prevalence of renal papillary necrosis was reported 65,000 per 100,000 patients with sickle cell disease.In developing countries, the incidence of renal papillary necrosis is 3900 per 100,000 persons.The prevalence of renal papillary necrosis increases with age. It commonly affects the elderly (>60 years).Renal papillary necrosis due to sickle cell disease commonly affects adults in the third and fourth decades.Renal papillary necrosis is more prevalent in women.

Risk Factors

Natural History, Complications & Prognosis

Common complications of renal papillary necrosis include Kidney infection and stones, chronic renal failure, kidney cancers, hypertension, anemia and ESRD. Prognosis depends on the underlying condition.

Diagnosis

The diagnosis of renal papillary necrosis is made by a history of having high-risk conditions such as analgesic abuse and urinalysis and Ultrasound, CT, or other imaging tests of the kidneys.

History and Symptoms

The most common symptoms of renal papillary necrosis include back pain, fever, bloody urine, presence of tissues in urine, Cloudy urine, dysuria, frequency, urgency and urinary incontinency. History of medical conditions such as diabetes and sickle cell disease and long term analgesics use such as acetaminophen and NSAIDS should be considered. If left untreated or progressed, symptoms of chronic renal failure may be developed.

Physical Examination

Common physical examination findings of renal papillary necrosis include fever, costovertebral angle tenderness, and hematuria.

Laboratory Findings

X-ray

CT Scan

CT urography is helpful in the diagnosis of renal papillary necrosis that shows multiple small accumulations of contrast media in the papillary regions near the calyx system. The lobster claw sign is a diagnostic finding on CT urography in the papillary subtype of renal papillary necrosis that develops due to elongation of the minor calyx fornices following ischemia and destruction of the renal papilla.

MRI

MRI can be used as a helpful alternative imaging test in children suspected renal papillary necrosis. On Magnetic resonance urography, renal papillary necrosis is characterized by classic signs of papillary necrosis including candle-flame appearance, Golf ball on a tee sign, lobster claw sign and clubbing of calyces.

Other Imaging Findings

Biopsy

On renal biopsy, renal papillary necrosis is characterized by necrosis of papilla, swelling and sloughing of papilla, mild inflammation and microcalcification at necrotic area.

Treatment

The mainstay of therapy in renal papillary necrosis is supportive care and treating the underlying cause such as discontinuation of analgesics. In severe cases, dialysis or renal replacement therapy may be required.

Medical Therapy

The mainstay of therapy is supportive care and treating the underlying cause.

Surgery

In severe cases of renal papillary necrosis leading to chronic kidney disease, dialysis or renal replacement therapy may be required.

Prevention

Effective measures for the primary prevention of renal papillary necrosis include controlling underlying diseases such as diabetes or sickle cell anemia, avoid taking over-the-counter analgesics and using the minimum dose of NSAIDs within the shortest time.

References

Template:WH Template:WS

Historical Perspective

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]


Overview

Renal papillary necrosis was first introduced by Friedrich in 1877, following urinary obstruction. Then, other associated factors such as diabetes, sickle cell disease and analgesics were found.

Discovery

Landmark Events in the Development of Treatment Strategies

Impact on Cultural History

    Famous Cases

      References

      1. Friedreich, N. (1877). “Ueber Necrose der Nierenpapillen bei Hydronephrose”. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 69 (2): 308–312. doi:10.1007/BF02326121. ISSN 0945-6317.
      2. 2.0 2.1 Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). “Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria”. Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.
      3. SPUHLER O, ZOLLINGER HU (1953). “[Chronic interstitial nephritis]”. Z Klin Med. 151 (1): 1–50. PMID 13137299.
      Classification

      Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]


      Overview

      Renal papillary necrosis may be classified according to the severity of renal parenchymal lesions into two subtypes: Medullary and Papillary.

      Classification


      Staging of Renal papillary necrosis


      References

      1. Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). “Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria”. Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.
      Pathophysiology

      Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

      Overview

      Renal papillary necrosis is a significant kidney disorder, which is associated with ischemia of the inner renal medulla and papilla due to chronic conditions such as diabetes, sickle cell disease, urinary tract obstruction, urinary tract infection and long term use of analgesics. Decreased prostaglandin synthesis and subsequent reduced renal blood flow is an important mechanism for developing renal papillary necrosis.

      Pathogenesis

      . [4]



      Gross Pathology

      Microscopic Pathology


      References

      1. 1.0 1.1 1.2 1.3 Brix AE (2002). “Renal papillary necrosis”. Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
      2. 2.0 2.1 Sabatini S (1984). “Pathophysiology of drug-induced papillary necrosis”. Fundam Appl Toxicol. 4 (6): 909–21. doi:10.1016/0272-0590(84)90229-x. PMID 6394414.
      3. 3.0 3.1 Geller SA, de Campos FPF (2013). “Renal papillary necrosis”. Autops Case Rep. 3 (4): 69–71. doi:10.4322/acr.2013.042. PMC 5453664. PMID 28584810.
      4. By BruceBlaus. When using this image in external sources it can be cited as:Blausen.com staff (2014). “Medical gallery of Blausen Medical 2014”. WikiJournal of Medicine 1 (2). DOI:10.15347/wjm/2014.010. ISSN 2002-4436. – Own work, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=31118599
      5. Jung DC, Kim SH, Jung SI, Hwang SI, Kim SH (2006). “Renal papillary necrosis: review and comparison of findings at multi-detector row CT and intravenous urography”. Radiographics. 26 (6): 1827–36. doi:10.1148/rg.266065039. PMID 17102053.
      6. Burrell JH, Yong JL, Macdonald GJ (1990). “Experimental analgesic nephropathy: changes in renal structure and urinary concentrating ability in Fischer 344 rats given continuous low doses of aspirin and paracetamol”. Pathology. 22 (1): 33–44. doi:10.3109/00313029009061423. PMID 2362779.
      7. Brater DC, Harris C, Redfern JS, Gertz BJ (2001). “Renal effects of COX-2-selective inhibitors”. Am J Nephrol. 21 (1): 1–15. doi:10.1159/000046212. PMID 11275626.
      8. Henderickx MMEL, Brits T, De Baets K, Seghers M, Maes P, Trouet D; et al. (2017). “Renal papillary necrosis in patients with sickle cell disease: How to recognize this ‘forgotten’ diagnosis”. J Pediatr Urol. 13 (3): 250–256. doi:10.1016/j.jpurol.2017.01.020. PMID 28341428.
      9. 9.0 9.1 9.2 “Renal Papillary Necrosis – American Urological Association”.
      10. “Renal papillary necrosis | Radiology Reference Article | Radiopaedia.org”.
      11. Lindvall N (1978). “Radiological changes of renal papillary necrosis”. Kidney Int. 13 (1): 93–106. doi:10.1038/ki.1978.12. PMID 713272.
      12. Gregg NJ, Courtauld EA, Bach PH (1990). “High resolution light microscopic morphological and microvascular changes in an acutely induced renal papillary necrosis”. Toxicol Pathol. 18 (1 Pt 1): 47–55. doi:10.1177/019262339001800107. PMID 2194275.
      Causes

      Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

      Overview


      Causes

      • There is a mnemonic for the causes of renal papillary necrosis[5] : POSTCARDS:
        • Pyelonephritis
        • Obstruction of the urogenital tract
        • Sickle cell disease
        • Tuberculosis
        • Cirrhosis
        • Analgesia/Alcohol abuse
        • Renal vein thrombosis
        • Diabetes mellitus
        • Systemic vasculitis

      References

      1. Brix AE (2002). “Renal papillary necrosis”. Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
      2. Sabatini S (1984). “Pathophysiology of drug-induced papillary necrosis”. Fundam Appl Toxicol. 4 (6): 909–21. doi:10.1016/0272-0590(84)90229-x. PMID 6394414.
      3. Henderickx MMEL, Brits T, De Baets K, Seghers M, Maes P, Trouet D; et al. (2017). “Renal papillary necrosis in patients with sickle cell disease: How to recognize this ‘forgotten’ diagnosis”. J Pediatr Urol. 13 (3): 250–256. doi:10.1016/j.jpurol.2017.01.020. PMID 28341428.
      4. Husband P, Howlett KA (1973). “Renal papillary necrosis in infancy”. Arch Dis Child. 48 (2): 116–20. doi:10.1136/adc.48.2.116. PMC 1648192. PMID 4690507.
      5. Kim, Seung Hyup (2011-11-19). Radiology Illustrated: Uroradiology. Springer Science & Business Media. p. 471. ISBN 9783642053221.

      [[Category:Disease]

      Differentiating Renal papillary necrosis from other Diseases

      Overview

      Differentiating Renal Papillary Necrosis From Other Diseases

      Renal papillary necrosis should be differentiated from other conditions presenting with acute flank or upper abdominal pain, hematuria, nausea and vomiting. The differentials include the following:[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]

      Category Disease History Signs and Symptoms Physical Examination Laboratory abnormalities
      Nausea/vomiting Hematuria Location of pain Fever Tachycardia Hypotension Hypertension Anorexia Constipation Rebound abdominal tenderness Urinary frequency/Urgency/Dysuria Costovetebral angle tenderness Pelvic Examination Rectal Examination Complete Blood Count (CBC) Urinalysis BUN Creatinine Stone analysis Urine Beta- hCG Abnormal Liver Function Tests (LFTs) Serum Amylase/Lipase Abdominal/Pelvic CT scan Serum Parathyroid hormone levels (PTH)

      Renal Pathology

      Nephrolithiasis + + + +/- +
      • Non-contrast CT scan may show stone as radiolucency
      +/-
      Pyelonephritis + + (microscopic) + + + +/- + + +
      • Globaly decreased contrast uptake
      •  Foci from abscess pockets
      Renal infarct + + + + +
      Renal papillary necrosis + (microscopic) + +/- + +
      Renal cell carcinoma + + (microscopic) + + +/-
      • Anemia
      • Non-contrast CT:
      • Contrast-enhanced:
        • Homogenous (small lesions) to irregular (large lesions) contrast enhancement
      Uretral stricture +/- +

      Gynecological Pathology

      Pelvic inflammatory disease
      • Right/left upper quadrant
      + + + + +
      • Thickening of the uterosacral ligaments
      • Haziness of the pelvic fat
      • Periovarian stranding
      • Enhancement of the adjacent peritoneum
      • Thick-walled, complex fluid collection with septa formation (abscess pockets)
      Ovarian torsion
      • Sudden acute pain
      • Sharp pain aggravated by walking
      • Intermittent/colicky pain
      + +
      • Twisted ovarian pedicle
      • Enlarged ovary (>4.0 cm)
      • Distended pedicle
      • Possible underlying ovarian lesion
      Ectopic pregnancy + + + + (if ruptured) +
      • Low platelet distribution width (decreased platelet activation)
      • Monocytosis
      + +/- N/A

      Prostate Pathology

      Prostatitis + + + +
      Prostatic cancer + + +

      Testicular Pathology

      Testicular torsion + + +/- +/-
      Orchitis + + + +/-

      Abdominal Pathology

      Cholecystitis + + + + + +/-
      • Gallbladder distention
      • Wall thickening
      • Mucosal hyperenhancement,
      • Pericholecystic fat stranding or fluid
      • Gallstones
      Appendicitis + + + + + +/-
      • Leukocytosis
      + (if perforation)
      Diverticulitis + + + + + + (if perforation)
      • Colonic wall thickening (wall thickness is greater than 3 mm on the short axis of the lumen)
      • Pericolic fat stranding
      Abdominal aortic aneurysm + + + (if rupture)
      • Ultrasound more sensitive than CT scan
      • CT scan may accurately predict the aneurysmal size
      • Helical CT has faster scanning time (30 to 60 seconds) and the ability to obtain all images in one breath hold
      Portal vein thrombosis + + + + + + (if bowel ischemia or infarction-secondary to extension of thrombus to superior mesenteric vein) + + (if bowel infarction, perforation)
      • On non-contrast CT:
        • Hyperdense thrombus
      • On contrast CT
        • Non-enhancing defect of bland thrombus
        • Tumor thrombus exhibits enhancement
      Duodenal ulcer + + + + + (if perforation) + (if bowel perforation)
      Ischemic colitis + + + + (if necrosis and sepsis) + + + + (if transmural necrosis) + (if bowel perforation)

      References

      1. Worcester EM, Coe FL (June 2008). “Nephrolithiasis”. Prim. Care. 35 (2): 369–91, vii. doi:10.1016/j.pop.2008.01.005. PMC 2518455. PMID 18486720.
      2. Semins MJ, Matlaga BR (February 2010). “Medical evaluation and management of urolithiasis”. Ther Adv Urol. 2 (1): 3–9. doi:10.1177/1756287210369121. PMC 3126068. PMID 21789078.
      3. Venkatesh L, Hanumegowda RK (June 2017). “Acute Pyelonephritis – Correlation of Clinical Parameter with Radiological Imaging Abnormalities”. J Clin Diagn Res. 11 (6): TC15–TC18. doi:10.7860/JCDR/2017/27247.10033. PMC 5535453. PMID 28764263.
      4. Garin EH, Olavarria F, Araya C, Broussain M, Barrera C, Young L (July 2007). “Diagnostic significance of clinical and laboratory findings to localize site of urinary infection”. Pediatr. Nephrol. 22 (7): 1002–6. doi:10.1007/s00467-007-0465-7. PMID 17375337.
      5. Lee DG, Jeon SH, Lee CH, Lee SJ, Kim JI, Chang SG (April 2009). “Acute pyelonephritis: clinical characteristics and the role of the surgical treatment”. J. Korean Med. Sci. 24 (2): 296–301. doi:10.3346/jkms.2009.24.2.296. PMC 2672131. PMID 19399273.
      6. Saeed K (2012). “Renal infarction”. Int J Nephrol Renovasc Dis. 5: 119–23. doi:10.2147/IJNRD.S33768. PMC 3437809. PMID 22969301.
      7. Mahamid M, Francis A, Abid A, Awawde M, Abu-Elhija O (2014). “Embolic renal infarction mimicking renal colic”. Int J Nephrol Renovasc Dis. 7: 157–9. doi:10.2147/IJNRD.S59745. PMC 4011809. PMID 24812524.
      8. Korzets Z, Plotkin E, Bernheim J, Zissin R (October 2002). “The clinical spectrum of acute renal infarction”. Isr. Med. Assoc. J. 4 (10): 781–4. PMID 12389340.
      9. Brix AE (2002). “Renal papillary necrosis”. Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
      10. Eknoyan G, Qunibi WY, Grissom RT, Tuma SN, Ayus JC (March 1982). “Renal papillary necrosis: an update”. Medicine (Baltimore). 61 (2): 55–73. PMID 7038374.
      11. Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM (October 2008). “Renal cell carcinoma: diagnosis, staging, and surveillance”. AJR Am J Roentgenol. 191 (4): 1220–32. doi:10.2214/AJR.07.3568. PMID 18806169.
      12. Ares Valdés Y, Amador Sandoval B, Morales JC, Alonso Domínguez F, Carballo Velásquez L, Fragas Valdés R, Shou Rodríguez A (September 2004). “[The role of CT scan in the diagnosis of renal cell carcinoma]”. Arch. Esp. Urol. (in Spanish; Castilian). 57 (7): 737–42. PMID 15536955.
      13. Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N (June 2010). “Imaging renal cell carcinoma with ultrasonography, CT and MRI”. Nat Rev Urol. 7 (6): 311–25. doi:10.1038/nrurol.2010.63. PMID 20479778.
      14. Tritschler S, Roosen A, Füllhase C, Stief CG, Rübben H (March 2013). “Urethral stricture: etiology, investigation and treatments”. Dtsch Arztebl Int. 110 (13): 220–6. doi:10.3238/arztebl.2013.0220. PMC 3627163. PMID 23596502.
      15. Mundy AR, Andrich DE (January 2011). “Urethral strictures”. BJU Int. 107 (1): 6–26. doi:10.1111/j.1464-410X.2010.09800.x. PMID 21176068.
      16. Maciejewski C, Rourke K (February 2015). “Imaging of urethral stricture disease”. Transl Androl Urol. 4 (1): 2–9. doi:10.3978/j.issn.2223-4683.2015.02.03. PMC 4708283. PMID 26816803.
      17. Soper DE (August 2010). “Pelvic inflammatory disease”. Obstet Gynecol. 116 (2 Pt 1): 419–28. doi:10.1097/AOG.0b013e3181e92c54. PMID 20664404.
      18. Paavonen J (October 1998). “Pelvic inflammatory disease. From diagnosis to prevention”. Dermatol Clin. 16 (4): 747–56, xii. PMID 9891675.
      19. Lee MH, Moon MH, Sung CK, Woo H, Oh S (December 2014). “CT findings of acute pelvic inflammatory disease”. Abdom Imaging. 39 (6): 1350–5. doi:10.1007/s00261-014-0158-1. PMID 24802548.
      20. Eggert J, Sundquist K, van Vuuren C, Fianu-Jonasson A (October 2006). “The clinical diagnosis of pelvic inflammatory disease–reuse of electronic medical record data from 189 patients visiting a Swedish university hospital emergency department”. BMC Womens Health. 6: 16. doi:10.1186/1472-6874-6-16. PMC 1624808. PMID 17054801.
      21. Washington C, Carmichael JC (December 2012). “Management of ischemic colitis”. Clin Colon Rectal Surg. 25 (4): 228–35. doi:10.1055/s-0032-1329534. PMC 3577613. PMID 24294125.
      22. Chawla YK, Bodh V (March 2015). “Portal vein thrombosis”. J Clin Exp Hepatol. 5 (1): 22–40. doi:10.1016/j.jceh.2014.12.008. PMC 4415192. PMID 25941431.
      23. “Imaging of Abdominal Aortic Aneurysms – – American Family Physician”.
      24. Aggarwal S, Qamar A, Sharma V, Sharma A (2011). “Abdominal aortic aneurysm: A comprehensive review”. Exp Clin Cardiol. 16 (1): 11–5. PMC 3076160. PMID 21523201.
      25. Destigter KK, Keating DP (August 2009). “Imaging update: acute colonic diverticulitis”. Clin Colon Rectal Surg. 22 (3): 147–55. doi:10.1055/s-0029-1236158. PMC 2780264. PMID 20676257.
      26. Hameed AM, Lam VW, Pleass HC (February 2015). “Significant elevations of serum lipase not caused by pancreatitis: a systematic review”. HPB (Oxford). 17 (2): 99–112. doi:10.1111/hpb.12277. PMC 4299384. PMID 24888393.
      27. “Imaging for Suspected Appendicitis – – American Family Physician”.
      28. “CT Findings of Acute Cholecystitis and Its Complications : American Journal of Roentgenology : Vol. 194, No. 6 (AJR)”.
      29. “Epididymitis and Orchitis: An Overview – – American Family Physician”.
      30. Jia JB, Houshyar R, Verma S, Uchio E, Lall C (January 2016). “Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology”. Eur J Radiol. 85 (1): 261–267. doi:10.1016/j.ejrad.2015.10.013. PMID 26526901.
      31. Bratt O, Lilja H (January 2015). “Serum markers in prostate cancer detection”. Curr Opin Urol. 25 (1): 59–64. doi:10.1097/MOU.0000000000000128. PMC 4315142. PMID 25393274.
      32. “Prostate Cancer (Prostate Carcinoma): Symptoms – National Library of Medicine – PubMed Health”.
      33. Eskicioğlu F, Özdemir AT, Turan GA, Gür EB, Kasap E, Genç M (November 2014). “The efficacy of complete blood count parameters in the diagnosis of tubal ectopic pregnancy”. Ginekol. Pol. 85 (11): 823–7. PMID 25675798.
      34. Sivalingam VN, Duncan WC, Kirk E, Shephard LA, Horne AW (October 2011). “Diagnosis and management of ectopic pregnancy”. J Fam Plann Reprod Health Care. 37 (4): 231–40. doi:10.1136/jfprhc-2011-0073. PMC 3213855. PMID 21727242.

      [[Category:Disease]

      Epidemiology and Demographics

      Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

      Overview

      The prevalence and demographic characteristics of renal papillary necrosis depend on the causative agent.

      Epidemiology and Demographics

      Prevalence

      Incidence

      Age

      Gender

      Race

      References

      1. 1.0 1.1 1.2 Brix AE (2002). “Renal papillary necrosis”. Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
      2. Pandya KK, Koshy M, Brown N, Presman D (1976). “Renal papillary necrosis in sickle cell hemoglobinopathies”. J Urol. 115 (5): 497–501. doi:10.1016/s0022-5347(17)59255-1. PMID 1271537.
      3. 3.0 3.1 Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). “Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria”. Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.
      4. Dahniya MH, Szmigielski W, Reddy CK, Hanna RM, Cherian MJ, Mattar MS; et al. (1992). “Renal papillary necrosis in Kuwait”. Trop Geogr Med. 44 (4): 331–7. PMID 1295143.
      5. Alhwiesh A (2014). “An update on sickle cell nephropathy”. Saudi J Kidney Dis Transpl. 25 (2): 249–65. doi:10.4103/1319-2442.128495. PMID 24625990.
      6. Henderickx MMEL, Brits T, De Baets K, Seghers M, Maes P, Trouet D; et al. (2017). “Renal papillary necrosis in patients with sickle cell disease: How to recognize this ‘forgotten’ diagnosis”. J Pediatr Urol. 13 (3): 250–256. doi:10.1016/j.jpurol.2017.01.020. PMID 28341428.
      Risk Factors

      Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

      Overview

      The most potent risk factor in the development of renal papillary necrosis is analgesics abuse. Other risk factors include pyelonephritis, diabetes, renal transplant rejection, sickle cell disease, urinary tract obstruction, cirrhosis, dehydration, hypotensive shock and hypoxia.

      Common Risk Factors


      References

      1. “Renal papillary necrosis: MedlinePlus Medical Encyclopedia”.
      2. Eknoyan G, Qunibi WY, Grissom RT, Tuma SN, Ayus JC (1982). “Renal papillary necrosis: an update”. Medicine (Baltimore). 61 (2): 55–73. doi:10.1097/00005792-198203000-00001. PMID 7038374.

      [[Category:Disease]

      Natural History, Complications and Prognosis

      Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

      Overview

      Common complications of renal papillary necrosis include Kidney infection and stones, chronic renal failure, kidney cancers, hypertension, anemia and ESRD. Prognosis depends on the underlying condition.

      Natural History

      Complications

      Prognosis

      References

      1. 1.0 1.1 “Renal Papillary Necrosis”. Medline. NIH. Retrieved 15 October 2015.
      Diagnosis

      Diagnosis

      Diagnostic Criteria | History and Symptoms | Physical Examination | X ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

      Treatment

      Treatment

      Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

      Case Studies

      Case Studies

      Case #1

      Template:WH Template:WS

      Looking for the patient version?

      Back to the patient-friendly article

      © 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH